November 15th, 2024
Description
Lung cancer is evolving rapidly, with several new drugs approved in the last year, and with more approvals in the last 5 years than in the last 3 decades. This fact (many new agents) as well as fact that many of the drugs are approved for uncommon, even rare subtypes of cancers mean that continuing education for practitioners is required. We believe that there is improved understanding of the benefits of broad based molecular testing for patients with newly diagnosed lung cancer, however the ability to implement this knowledge – how to apply specific drugs to specific patients with known molecular and immunologic abnormalities – is a great challenge. We have firm data that availability of appropriate testing leads to improved outcomes and that use of blood based NGS testing shortens time to appropriate treatment however rates of testing remain low, especially in the perioperative setting where recent data show only about half of patients
receiving appropriate testing in some reports (https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.8047) thus definitively proving the unmet need for more education.
For pricing information, see pricing tab below.
Dates and Times
Start: 11/15/2024 12:00 AM
End: 11/15/2024 7:00 PM
Objectives
1. To identify the role and application of biomarker testing to guide preoperative therapy for patients with potentially resectable lung cancer
2. To integrate guideline recommendations into clinical practice regarding biomarker testing for patients with all stages of lung cancer
3. To employ broad based biomarker testing prior to starting treatment for NSCLC
4. To apply repeat biopsy, blood base biopsies, and treatment selection at time of progression on first line therapies
Pricing
| Tier | Price |
|---|---|
| Registration | $0.00 |
Location
Grand Event Center
820 Goodale Blvd.
Columbus, OH 43212
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.